FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine, particularly to application of an antiviral agent - 2-methylthio-6-nitro-1,2,4-triazolo[5,1-c]-1,2,4-triazin-7-one dehydrate sodium salt (hereinafter - the Agent) for preventing and treating viral diseases caused by a tick-borne encephalitis virus. Also, there is described method for preventing and treating conditions caused by the tick-borne encephalitis virus in humans and animals involving introduction of the Agent presented above to humans and animals.
EFFECT: extended range of the drug preparations possessing a wide spectrum of action and used for treating and preventing tick-borne encephalitis.
20 cl, 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND AGENT ACTIVATING IRF-3 FOR TREATING AND PREVENTING DISEASES CAUSED BY (+) RNA CONTAINING VIRUSES | 2012 |
|
RU2518314C2 |
METHOD FOR PREVENTION AND TREATMENT OF DANGEROUS NEUROVIRAL INFECTIONS | 2016 |
|
RU2642312C1 |
AGENT ELICITING PROPHYLACTIC AND CURATIVE EFFECT IN INFECTION WITH TICK-BORNE ENCEPHALITIS VIRUS | 2003 |
|
RU2242238C1 |
ANTIVIRAL MEDICINE | 1991 |
|
RU2038083C1 |
ANTIVIRAL PREPARATION | 1994 |
|
RU2071323C1 |
ANTIVIRAL AGENT | 1991 |
|
RU2005475C1 |
AGENT FOR TREATMENT AND PROPHYLAXIS OF VIRAL TICK-BORNE ENCEPHALITIS INDUCED IN THE EXPERIMENT | 1986 |
|
RU2025126C1 |
PREPARATION FOR TREATMENT AND PROPHYLAXIS OF VIRAL DISEASES | 2000 |
|
RU2185822C2 |
INJECTION SOLUTION FOR TREATING VIRAL DISEASES SPECIFIED IN H1N1, H3N2, H5N1 INFLUENZA, TICK-BORNE ENCEPHALITIS AND WEST NILE FEVER | 2013 |
|
RU2574007C2 |
ADMINISTRATION OF Arg-Pro-Gly-Pro PEPTIDE AS ANTIVIRAL AGENT FOR ANIMALS | 2009 |
|
RU2414235C1 |
Authors
Dates
2012-03-10—Published
2010-06-01—Filed